Compilation of Cancer Therapy Protocol Summaries

Compilation of Cancer Therapy Protocol Summaries PDF Author: International Cancer Research Data Bank
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 764

Get Book

Book Description


Compilation of Cancer Therapy Protocol Summaries

Compilation of Cancer Therapy Protocol Summaries PDF Author:
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 738

Get Book

Book Description
Detailed outlines of ongoing experimental clinical trials. Data may also be retrieved in CLINPROT. Classified arrangement according to site. Each entry gives such information as investigator and address, objective, protocol outline, and dosage schedule. Tumor, agent, and protocol organizational number indexes. Miscellaneous appendixes.

Compilation of Experimental Cancer Therapy Protocol Summaries

Compilation of Experimental Cancer Therapy Protocol Summaries PDF Author:
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 608

Get Book

Book Description


Compilation of Experimental Cancer Therapy Protocol Summaries

Compilation of Experimental Cancer Therapy Protocol Summaries PDF Author:
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 592

Get Book

Book Description


Compilation of Clinical Protocol Summaries

Compilation of Clinical Protocol Summaries PDF Author: Smithsonian Science Information Exchange. Current Cancer Research Project Analysis Center
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 412

Get Book

Book Description


Compilation of Clinical Protocol Summaries

Compilation of Clinical Protocol Summaries PDF Author: International Cancer Research Data Bank
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 395

Get Book

Book Description


Transforming Clinical Research in the United States

Transforming Clinical Research in the United States PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309163358
Category : Medical
Languages : en
Pages : 151

Get Book

Book Description
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides medical decisions in the United States falls far short of this vision. The process of generating medical evidence through clinical trials in the United States is expensive and lengthy, includes a number of regulatory hurdles, and is based on a limited infrastructure. The link between clinical research and medical progress is also frequently misunderstood or unsupported by both patients and providers. The focus of clinical research changes as diseases emerge and new treatments create cures for old conditions. As diseases evolve, the ultimate goal remains to speed new and improved medical treatments to patients throughout the world. To keep pace with rapidly changing health care demands, clinical research resources need to be organized and on hand to address the numerous health care questions that continually emerge. Improving the overall capacity of the clinical research enterprise will depend on ensuring that there is an adequate infrastructure in place to support the investigators who conduct research, the patients with real diseases who volunteer to participate in experimental research, and the institutions that organize and carry out the trials. To address these issues and better understand the current state of clinical research in the United States, the Institute of Medicine's (IOM) Forum on Drug Discovery, Development, and Translation held a 2-day workshop entitled Transforming Clinical Research in the United States. The workshop, summarized in this volume, laid the foundation for a broader initiative of the Forum addressing different aspects of clinical research. Future Forum plans include further examining regulatory, administrative, and structural barriers to the effective conduct of clinical research; developing a vision for a stable, continuously funded clinical research infrastructure in the United States; and considering strategies and collaborative activities to facilitate more robust public engagement in the clinical research enterprise.

Molecular Biology of The Cell

Molecular Biology of The Cell PDF Author: Bruce Alberts
Publisher:
ISBN: 9780815332183
Category : Cytology
Languages : en
Pages : 0

Get Book

Book Description


Protocol Handbook for Cancer Biology

Protocol Handbook for Cancer Biology PDF Author: Gauri Misra
Publisher: Academic Press
ISBN: 0323898173
Category : Science
Languages : en
Pages : 222

Get Book

Book Description
Protocol Handbook for Cancer Biology brings together a comprehensive collection of the methods used for cancer assessment, diagnostics, and therapeutics. Various protocols are discussed along with alternative strategies, including the advantages and limitations of techniques that have been used in labs globally. These protocols are presented by cancer biology experts based on their real-world experience. The protocols in this book will be a valuable resource for cancer researchers and graduate students, who can utilize the techniques described to conduct research more efficiently and successfully. Presents comprehensive protocols used for cancer assessment, diagnostics, and therapeutics all in one place Encompasses alternative strategies considering the requirements of the end user and taking into consideration diverse research settings Discusses limitations and advantages of each method in experimental design and execution, thus saving time during the research process

Cancer Care for the Whole Patient

Cancer Care for the Whole Patient PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309134161
Category : Medical
Languages : en
Pages : 454

Get Book

Book Description
Cancer care today often provides state-of-the-science biomedical treatment, but fails to address the psychological and social (psychosocial) problems associated with the illness. This failure can compromise the effectiveness of health care and thereby adversely affect the health of cancer patients. Psychological and social problems created or exacerbated by cancer--including depression and other emotional problems; lack of information or skills needed to manage the illness; lack of transportation or other resources; and disruptions in work, school, and family life--cause additional suffering, weaken adherence to prescribed treatments, and threaten patients' return to health. Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. All patients with cancer and their families should expect and receive cancer care that ensures the provision of appropriate psychosocial health services. Cancer Care for the Whole Patient recommends actions that oncology providers, health policy makers, educators, health insurers, health planners, researchers and research sponsors, and consumer advocates should undertake to ensure that this standard is met.